Replies to post #9270 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

I feel a need to correct you. First, this is a classified as class 1 which is very rapid. Secondly, what do you think happened to all the data collected during the testing phase on the analyzers? This is what will be sunbmitted. Also, add Goshen, Bhlokin, and quite possibly other phamaceutical companies and this leads me to believe we are closer to submission than you think. Reread anything in the previous press releases quoting Dr Moro and you will deduce the same thing I am telling you. It is a difference of opinion only, and it is my opinion you have yours.